Century Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:IPSC) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 28.33 M24.22 M34.62 M27.59 M25.58 M 112.02 M Cash from investing activities -5.45 M30.61 M27.93 M32.54 M24.67 M 115.75 M Cash from financing activities 273 K-602 K120 K00 -482 K Free cash flow 28.33 M24.22 M34.15 M27.27 M25.39 M 111.03 M

ニュース

TD Cowen、Century Therapeutics株を買い推奨で新規カバレッジ開始

TD Cowen initiates Century Therapeutics stock rating at Buy

クリア・ストリート、センチュリー・セラピューティクスの株式に買い推奨を維持、目標価格$6.60

Oracle, Palantir among market cap stock movers on Monday

Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know

Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler

クリア・ストリート、センチュリー・セラピューティクスの目標株価を6.60ドルに引き下げ

Century Therapeutics stock price target lowered to $6.60 at Clear Street

Century Therapeutics secures $135 million in private placement

FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug

Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain

Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors